Good morning :)
Place Order
Add to Watchlist

Sanofi India Ltd

SANOFI

Sanofi India Ltd

SANOFI
Health CarePharmaceuticals
SmallcapWith a market cap of ₹15,644 cr, stock is ranked 414
Low RiskStock is 1.90x as volatile as Nifty
6,772.250.32% (-22.05)
6,772.250.32% (-22.05)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹15,644 cr, stock is ranked 414
Low RiskStock is 1.90x as volatile as Nifty

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹15,644 cr, stock is ranked 414
Low RiskStock is 1.90x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
29.5515.412.46%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.446.570.51%

Forecast & Ratings

Detailed Forecast 
100%
Analysts have suggested that investors can buy this stock

from 4 analysts

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Sanofi India Limited is engaged in the manufacture and sale of pharmaceutical products.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Loading...

Financial YearFY 2023TTM
Total Revenue2,934.202,514.50
Raw Materialssubtract1,493.401,780.10
Power & Fuel Costsubtract14.60
Employee Costsubtract370.60
Selling & Administrative Expensessubtract332.90
Operating & Other expensessubtract-164.10
Depreciation/Amortizationsubtract39.6038.20
Interest & Other Itemssubtract1.701.40
Taxes & Other Itemssubtract242.60165.40
EPS261.78229.87
DPS167.00104.45
Payout ratio0.640.45

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2021

Annual report

PDF

Investor Presentation

Mar 17PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Sanofi India Ltd25.9515.412.46%
Sun Pharmaceutical Industries Ltd46.316.610.73%
Cipla Ltd30.404.670.84%
Torrent Pharmaceuticals Ltd65.4215.810.87%

Price Comparison

Compare SANOFI with any stock or ETF
Compare SANOFI with any stock or ETF
SANOFI
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding60.40%11.56%11.26%5.78%11.00%

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Shareholding History

JunSepDec '23MarJunSep6.72%6.80%6.31%6.11%5.81%5.78%

Mutual Funds Holding Trend

Mutual Fund Holding

Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

Top 5 Mutual Funds holding Sanofi India Ltd




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
SBI FUNDS MANAGEMENT PVT LTD#SBI MF-SBI MAGNUM MIDCAP FUND DIRECT PL GROWTH

Growth
1.8023%1.26%0.94%20/80 (+12)
Aditya Birla Sun Life Frontline Equity Fund - Growth - Direct Plan

Growth
1.1110%0.55%-0.06%32/97 (+1)
Nippon India Pharma Fund - Growth - Direct Plan

Growth
1.0375%1.85%-0.17%22/36 (-3)

Compare 3-month MF holding change on Screener

Insider Trades & Bulk Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateMay 3, 2024

Final
Final | Div/Share: ₹117.00

Dividend/Share

117.00

Ex DateEx Date

May 3, 2024

Cash Dividend

Ex DateEx DateMar 7, 2024

Interim
Interim | Div/Share: ₹50.00

Dividend/Share

50.00

Ex DateEx Date

Mar 7, 2024

Cash Dividend

Ex DateEx DateApr 28, 2023

Special
Special | Div/Share: ₹183.00

Dividend/Share

183.00

Ex DateEx Date

Apr 28, 2023

Cash Dividend

Ex DateEx DateApr 28, 2023

Final
Final | Div/Share: ₹194.00

Dividend/Share

194.00

Ex DateEx Date

Apr 28, 2023

Cash Dividend

Ex DateEx DateAug 5, 2022

Special
Special | Div/Share: ₹193.00

Dividend/Share

193.00

Ex DateEx Date

Aug 5, 2022

News & Opinions
Corporate
Sanofi India to discuss results

Sanofi India will hold a meeting of the Board of Directors of the Company on 7 November 2024.Powered by Capital Market - Live

2 weeks agoCapital Market - Live
Spotlight
Sanofi India Ltd up for fifth session

Sanofi India Ltd is up for a fifth straight session in a row. The stock is quoting at Rs 7265.05, up 1.86% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is down around 0.57% on the day, quoting at 25136.35. The Sensex is at 82165.57, down 0.47%. Sanofi India Ltd has risen around 13.34% in last one month. Meanwhile, Nifty Pharma index of which Sanofi India Ltd is a constituent, has risen around 6.86% in last one month and is currently quoting at 23014.3, up 0.21% on the day. The volume in the stock stood at 27179 shares today, compared to the daily average of 18790 shares in last one month.The PE of the stock is 33.42 based on TTM earnings ending June 24.Powered by Capital Market - Live

1 month agoCapital Market - Live

Sanofi gets drug regulator nod to market RSV therapy in India

3 months agoEconomic Times

Sanofi gets regulatory nod for RSV product in India

3 months agoThe Hindu Businessline

Sanofi India stock falls 2% on weak June quarter results; profit falls 16%

3 months agoBusiness Standard

Sanofi India standalone net profit declines 15.87% in the June 2024 quarter

3 months agoBusiness Standard
Earnings
Sanofi India standalone net profit declines 15.87% in the June 2024 quarter

Net profit of Sanofi India declined 15.87% to Rs 103.40 crore in the quarter ended June 2024 as against Rs 122.90 crore during the previous quarter ended June 2023. Sales declined 9.98% to Rs 463.50 crore in the quarter ended June 2024 as against Rs 514.90 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales463.50514.90 -10 OPM %24.9623.62 - PBDT120.10136.40 -12 PBT111.10127.30 -13 NP103.40122.90 -16 Powered by Capital Market - Live

3 months agoCapital Market - Live

Sanofi India Ltd spurts 1.9%, rises for fifth straight session

3 months agoBusiness Standard
Spotlight
Sanofi India Ltd spurts 1.9%, rises for fifth straight session

Sanofi India Ltd gained for a fifth straight session today. The stock is quoting at Rs 6682, up 1.9% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is down around 0.23% on the day, quoting at 24358.45. The Sensex is at 79975.9, down 0.22%. Sanofi India Ltd has slipped around 0.07% in last one month. Meanwhile, Nifty Pharma index of which Sanofi India Ltd is a constituent, has slipped around 7.16% in last one month and is currently quoting at 20908.5, up 0.17% on the day. The volume in the stock stood at 11821 shares today, compared to the daily average of 15692 shares in last one month.The PE of the stock is 26.61 based on TTM earnings ending March 24.Powered by Capital Market - Live

3 months agoCapital Market - Live

Sanofi Initiates Voluntary Recall Of Allegra, Combiflam Suspensions In India Over Contamination Concerns - News18

3 months agoNews18